ValuEngine Upgrades Opiant Pharmaceuticals to STRONG BUY

  For today’s bulletin, we take a look at our latest STRONG BUY and BUY upgrades and focus on one of our top upgrades for the day, Opiant Pharmaceuticals (OPNT). We also provide a link to download a FREE STOCK REPORT on the company VALUATION WATCH: Overvalued stocks now make up 61.95% of our stocks … Read moreValuEngine Upgrades Opiant Pharmaceuticals to STRONG BUY